Peter Virsik
Chief Operating Officer at ESSA PHARMA INC.
Net worth: 68 826 $ as of 2024-04-29
Peter Virsik active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ESSA PHARMA INC. | Chief Operating Officer | 2016-07-31 | - |
Career history of Peter Virsik
Former positions of Peter Virsik
| Companies | Position | Start | End |
|---|---|---|---|
| XENOPORT, INC. | Corporate Officer/Principal | 2004-12-31 | 2014-12-31 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 1999-12-31 | 2004-12-31 |
Training of Peter Virsik
| Kellogg School of Management | Masters Business Admin |
| University of Michigan | Graduate Degree |
| University of California, Berkeley | Undergraduate Degree |
Statistics
International
| United States | 6 |
| Canada | 2 |
Operational
| Corporate Officer/Principal | 2 |
| Masters Business Admin | 1 |
| Graduate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| ESSA PHARMA INC. | Health Technology |
| GILEAD SCIENCES, INC. | Health Technology |
| Private companies | 1 |
|---|---|
XenoPort, Inc.
 XenoPort, Inc. Pharmaceuticals: MajorHealth Technology XenoPort, Inc. operated as a biopharmaceutical company. Its products included horizant and regnite. The company was founded by Ronald W. Barrett, William J. Dower and Mark A. Gallop on December 17, 1999 and was headquartered in Atlanta, GA. | Health Technology |
- Stock Market
- Insiders
- Peter Virsik
- Experience
